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Background: Many studies have found considerable variations in the resource intensity of physical therapy
episodes. Although they have identified several patient- and provider-related factors, few studies have examined
their relative explanatory power. We sought to quantify the contribution of patients and providers to these
differences and examine how effective Swiss regulations are (nine-session ceiling per prescription and bonus for
first treatments).
Methods: Our sample consisted of 87,866 first physical therapy episodes performed by 3,365 physiotherapists
based on referrals by 6,131 physicians. We modeled the number of visits per episode using a multilevel log linear
regression with crossed random effects for physiotherapists and physicians and with fixed effects for cantons. The
three-level explanatory variables were patient, physiotherapist and physician characteristics.
Results: The median number of sessions was nine (interquartile range 6–13). Physical therapy use increased with
age, women, higher health care costs, lower deductibles, surgery and specific conditions. Use rose with the share of
nine-session episodes among physiotherapists or physicians, but fell with the share of new treatments. Geographical
area had no influence. Most of the variance was explained at the patient level, but the available factors explained
only 4% thereof. Physiotherapists and physicians explained only 6% and 5% respectively of the variance, although
the available factors explained most of this variance. Regulations were the most powerful factors.
Conclusion: Against the backdrop of abundant physical therapy supply, Swiss financial regulations did not restrict
utilization. Given that patient-related factors explained most of the variance, this group should be subject to closer
scrutiny. Moreover, further research is needed on the determinants of patient demand.
Keywords: Physical therapy, Episodes of care, Explained variation, Multilevel models, Crossed random effectsBackground
Interest in physical therapy utilization has grown in re-
cent decades. In the United States, national inflation-
adjusted expenditures for spine-related physical therapy
have increased by 78% between 1997 and 2005, which is
more than the 65% rise in total estimated care expen-
ditures for the condition [1]. Several authors tried to* Correspondence: patricia.halfon@chuv.ch
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unless otherwise stated.understand if physical therapy is used properly in com-
paring its utilization in different settings. They found
variations across countries in terms of the intensity of
physical therapy per treatment episode [2]. There is a
variety of acute or chronic conditions justifying physical
therapy, one of the main complaint being back pain
[3,4]. The treatment of this condition required an aver-
age of five sessions in United Kingdom, while the US
average was 11 [5,6].
Variations in physical therapy use were analyzed based
on the propensity to start physical therapy [3,7-10], the
number of sessions per treatment episode [9,11-13] andThis is an Open Access article distributed under the terms of the Creative
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nants of the intensity of physical therapy use, highlighting
the role of both health-related factors like age, gender, site
and severity of the condition and poor health [1,8,11-15]
and others, such as insurance status, education level, in-
come and urban residence [1,12,13,15]. However, even
after most of these factors are taken into account, the
treatment intensity can still vary substantially between pa-
tients [12,16]. A Dutch study suggested that there was an
overuse of physical therapy for lower back pain; patients
with acute complaints, in particular, attended a much
higher number of sessions than recommended. Moreover,
only a minority of patients with lower back pain was
treated according to national physical therapy guidelines
[17]. The introduction of professional guidelines coupled
with national volume policy led to a decline in the number
of physical therapy appointments and an increase in
the use of evidence-based methods to treat lower back
pain [18].
We were unable to find any analyses of the relative
role of patients, physicians, physiotherapists and finan-
cing regulations on the volume of physical therapy used.
Switzerland is an interesting setting because there is a
high density of physiotherapists, as well as a number of
control mechanisms in place (deductibles, ceiling per
prescription, and higher fees for first session). The den-
sity of physiotherapists is estimated at 1/700 inhabitants,
which is twice the average density observed in Europe
[19]. Roughly half of physiotherapists are in private prac-
tice [20]. In 2006, physical therapy was responsible for
7.5% of allied care costs and 1.3% of ambulatory health
care services costs (including auxiliary services such as
transport, radiology and laboratory) [21].
The primary objective of our study was to ascertain
the extent to which the volume of physical therapy per
treatment episode depended on patient characteristics
and/or on physician and physiotherapist behaviors, and
whether Swiss regulations were effective. To this end, we
used routinely collected data on a large national repre-
sentative sample of insured, which enabled us to analyze
a broad range of conditions.
Methods
Setting
In Switzerland, the compulsory health insurance system
requires a physician referral for physical therapy treat-
ment. The insured pay out 100% of the costs until the
deductible is reached (100 to 2500 Swiss francs depend-
ing on the policy chosen by the insured) and continue to
pay 10% of additional expenses up to a fixed ceiling.
Cantons may restrict the opening of new private physical
therapy practices, although this has yet to happen.
Patients are free to choose their therapist, who are paid
according to a set price per session and depending onthe type of service they provide (general physical therapy,
complex session, horse therapy, manual lymphatic drain-
age). They may also charge additional fees for special ser-
vices (including swimming pool and home treatment) [22].
For many years regulations have placed two main con-
straints on physical therapy use. First, there is a maximum
of nine sessions per physician prescription; a new pre-
scription is required to repeat the treatment (maximum of
9 sessions), but there is no limitation on the number of
prescriptions the insured can have if the same condition
requires subsequent treatment. Second, the fee for the first
session of a new treatment is higher. Regarding long-term
treatments (>36 sessions), the insurer, after consulting
with the referring physician, is entitled to demand medical
checks, impose time limits on treatment and restrict the
type of physical therapy. In spite of physician gatekeeping,
physiotherapists are free to choose the therapy they ad-
minister and are expected to limit the number of sessions
to patient needs and health objectives regardless of the
original physician prescription. Since the end of the study
period, neither the organization of the physiotherapy pro-
fession nor the regulations have changed.
Studied population
We undertook an observational study based on routine
data from four Swiss health insurers, covering 2.02 million
insured enrollees (27% of the Swiss population), of whom
1.68 million were followed in 2005 and 2006. Data in-
cluded all claims for ambulatory services, dispensed
drugs and hospitalizations. Although cantonal distribu-
tion differed markedly between this population and the
general Swiss population - reflecting the preferential
coverage that the four health insurance companies of-
fered in certain cantons - the age, gender and deductible
distribution were similar [23]. We retained all the in-
sured, followed until 31 December 2006, who had their
first physical therapy session in 2005. We included all
sessions delivered by licensed physiotherapists and out-
patient hospitals. Insurers’ data are not publicly avail-
able and were supplied for the sole purpose of the
present research project, which received Swiss Federal
Office of Public Health support [24]. Due to the fact
that physiotherapists are paid directly by insurers, we
expect few inaccuracies in the data collected for billing
purposes. Physicians and physiotherapists had their own
anonymous identification number. All data on patients
and care providers were also anonymous and contained
no information, such as date of birth or ZIP code, which
would make it possible to identify individuals [25].
Conceptual model
There are four determinants that could possibly influence
the volume of physical therapy (Figure 1): patient needs,
provider practices (physicians and physiotherapists),
Figure 1 Conceptual model.
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text variables.
Dependent variable
The outcome variable was the number of physical ther-
apy sessions per treatment episode. An episode began
with the first session of a new treatment (identified by a
specific fee position) and encompassed all sessions pro-
vided by a physiotherapist following a patient referral by
a physician. To count as an episode, the gap between
consecutive visits had to be less than six months and no
new treatment had been undertaken. The unit of ob-
servation was thus the specific encounter between the
patient and the physician/physiotherapist. To eliminate
incomplete observations with potentially truncated in-
formation on the number of sessions, we excluded epi-
sodes that involved appointments between 1 July and 31
December 2006. Figure 2 clarifies the criteria we used to
delineate the episodes of physical therapy care that we
were to study. All studied episodes (numbered 1, 2 and
6.2 in Figure 2) began in 2005 (January 1 to December
31, 2005), involved follow-ups of two years, and featured
no sessions during the second semester of 2006. We
excluded episodes beginning in 2006 (numbered 5 in
Figure 2; not part of the studied population), without
follow-up in 2006 (numbered 4 in Figure 2; possibly
right truncated) or with a last session during the second
semester of 2006 (numbered 3; possibly right truncated
because the episode may have involved additional ses-
sions in 2007). We also excluded episodes that did not
entail a first session (episode 6.1, left truncated). Patients
might have multiple episodes (episodes 7.1 and 7.2), if a
specific fee marked the beginning of a new episode(allowed for a condition involving a new body site
whatever time elapsed between two consecutive visits to
the same physiotherapist), or if the patient switched
to another physiotherapist or was referred by another
physician.
Independent variables
We characterized patient needs by age, gender, nature of
the main condition and co-morbidity burden.
As no information on reasons for seeking ambulatory
care is routinely collected in Switzerland, we derived cli-
nical conditions for physical therapy referral from three
sources: inpatient diagnoses and procedures, dispensed
outpatient drugs and the specialization of the referring
physician. Inpatient diagnoses (International Classification
of Diseases, 10th Revision: ICD-10 codes) and procedures
(International Classification of Diseases, 9th Revision,
Clinical Modification: ICD-9-CM codes) were linked to
insurers’ data via the anonymous linkage code procedure
of the Federal Statistical Office (FSO); only a sequential
number was delivered [26]. In 2005 and 2006, pharmacists
systematically sent drug codes (called pharmacodes) and
dispensation dates to insurers for billing purposes.
We used SQLape® grouper [27], which is suited to the
nomenclatures used in Switzerland (adaptation of ICD-10
diagnostic codes and ICD-9-CM procedures codes, Ana-
tomical Therapeutical Chemical ATC classification codes
from transcoding pharmacodes) to allocate patients to one
of the mutually exclusive morbidity groups described in
Additional file 1. Hospital diagnoses and interventions,
as well as drug-inferred illnesses were retained if they
occurred concurrently with a physical therapy episode.
Where clinical information was unavailable, we allocated
Figure 2 Definition of studied episodes.
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sician (e.g. orthopedics, psychiatry, neurology, surgery or
rheumatology). If a patient was assigned to several groups,
we retained only one according to a hierarchical cate-
gorization (see Additional file 1).
We estimated the co-morbidities burden by means of
the cumulated cost of care services in 2005, exclusive
of physiotherapist costs, based on the hypothesis that
higher medical costs reflect more co-morbid conditions
or poorer overall health status.
We characterized physicians and physiotherapists by
their anonymous identifiers and by the variation co-
efficients of the number of sessions per episode. We
hypothesized that a larger variation coefficient might re-
flect a greater propensity on the part of the therapist to
respond to the wishes of the patient (responsiveness in
Figure 1).
Swiss funding regulations are based on three measures:
deductibles from patient out- of-pocket expenses (to
discourage discretionary care consumption), the nine-
session cap for prescriptions (to limit use for acute con-
ditions and encourage the regular re-evaluation of health
benefits for chronic ailments), and a bonus for new treat-
ments (to incentivize physiotherapists to treat new patients
rather than extend the treatment of existing patients). The
expected relationship between the propensity of a provider
to use a set of nine sessions and the volume of physical
therapy was not clear-cut, due to the fact that the cap on
treatment episodes can both curb and encourage overuse.
A high proportion of new treatments per provider was ex-
pected to shrink the volume of physical therapy expend-
iture per treatment episode.Context variables may also modify the outcome, if
there are several physicians or physiotherapists involved
in the treatment of one condition, leading to a spurious
splitting of episodes. For instance, these biases were
caused by the use of locum physiotherapists to provide
holiday cover, the decision of the patient to continue
their treatment with a physiotherapist closer to where
they lived or the renewal of treatment made by another
physician.
To overcome geographical differences in provider
densities, we considered the canton where patients lived
and whether they lived in an urban setting. The FSO
classifies residency at four levels, the most urban being
one of the 62 large Swiss towns [28].
Statistical analysis
The data had a hierarchical and cross-classified struc-
ture, with patients (level 1) nested within the cells of the
cross-classification of physicians and physiotherapists
(both at level 2, as physicians had ongoing relationships
with several physiotherapists, and physiotherapists with
multiple physicians, see Figure 3). Physicians and phy-
siotherapists were nested within cantons (level 3). We
therefore used a multilevel regression model with crossed
random effects for physiotherapists and physicians and
with fixed effects for cantons [29,30]. We assessed po-
tentially explanatory variables at their various levels (see
Figure 3). One quarter of patients had multiple episodes
over time; adjusting for these correlations would drama-
tically increase modeling complexity [31]. We therefore
restricted our analyses to the first episode per patient.
Although this strategy did not use all the information
Figure 3 Hierarchical and cross-classified data structure.
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the large sample size and the time-invariant explanatory
factors.
The dependent variable was the number of sessions
per physical therapy episode. It is in principle a count
variable. However, as number of sessions varied from 1
to 330 and the distribution was highly right-skewed, the
variable was log-transformed. This allowed to nicely
symmetrize the distribution of the outcome (thereby
defining a log-linear or semi-log model), making it
appropriate for analysis by multilevel methods for linear
models. This was of great advantage given the well-
known difficulty in reliably estimating such complex
multilevel generalized linear models for count data [32].
Another advantage of our approach is that the order two
moment was independent from the order one moment,
which is not the case with the more constrained and less
general Poisson or Negative Binomial models. We, there-
fore, analyzed the log-dependent variable by methods for
multilevel-cross-classified linear models [33]. In a semi-
log model, the regression coefficient associated with a
particular variable estimates the semi-elasticity, i.e. the
percentage change (in linear approximation), of the num-
ber of sessions for a unit change of the independent vari-
able (log(y) = β0 + β1x + ε and d log(y)/dx = (dy/y)/dx = β1).
The unconditional model used to partition the overall
variance across the levels is written in Additional file 2,
part 1. The conditional model used to quantify the con-
tribution of patient, physician and physiotherapist char-
acteristics to explaining the outcome variance is written
in Additional file 2, part 2.
The total unexplained variance in the outcome vari-
able was partitioned into the three variance components:patient (level 1), physician (level 2), and physiotherapist
(level 2’) by the appropriate intra-class correlation co-
efficient (ICC) [34]. The proportion of variation (PEV)
at each level that was explained by the various factors,
as well as the overall explained variance were computed
using the unconditional and conditional estimated re-
sidual variances, which is akin to computing the extra
contribution to the model R2 when the additional set of
predictors is included in the regression model (i.e. the
square of the multiple semi-partial correlation coeffi-
cient) [34,35]. Unless the regressors are all orthogonal,
the factor-specific PEVs do not add up to the total PEV,
the difference representing the collinearity effect due to
the inclusion of all regressors in the model [36].
To assess the impact of the three “manageable” variables
(deductibles, proportion of nine-session sets and new
treatments) on the number of sessions, we used a back-
transformation to compute the predictions on the original
scale [37]. Note that the semi-elasticity allows us to
compute the percentage change, whereas the back-
transformation approach makes it possible to calcu-
late the absolute difference in the number of sessions
provided.
To assess the impact of the most and least parsimoni-
ous practices, we computed empirical Bayes estimates of
the random effects for both physicians and physiothera-
pists. We also calculated the difference in the number of
sessions between providers at the 2.5 and 97.5 percen-
tiles of the distribution [34].
Using SAS 9.3, we estimated the regression models by
maximum likelihood and assessed the goodness of fit
using scatter plots of marginal and conditional residuals
versus fitted values.
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We identified 122,841 patients who had received phy-
sical therapy during 2005. The total number of treat-
ment episodes was 169,305. These were dispensed by
4,029 physiotherapists based on referrals by 9,476 phy-
sicians. The decision to include only the patients’ first
episode and to exclude physicians and physiotherapists
with only one observation (missing coefficient of variation)
led to a studied population of 87,866 episodes dispensed
by 3,365 physiotherapists based on referrals by 6,131
physicians.
Table 1 compares the source and studied population.
The latter exhibited a weaker severity: younger subjects,
fewer conditions assigned to a clearly defined musculo-
skeletal condition (16% vs 26%), weaker co-morbidity
burden, and less frequent incidence of treatment man-
agement by several care providers (more than 95% were
treated by a single physician and physiotherapist versus
58% and 69% respectively in the source population). In
contrast, physician- and physiotherapist-related variables
were similar in the two samples.
The median number of sessions per episode was nine
(interquartile range 6–13); the distribution had a long
right tail with a maximum of 330. Such cases, which
reflect the existence of chronic illness management, for
instance provision of respiratory support, substantiate
our choice of applying the log-linear modelling of data.
In bivariate analyses, higher use was associated with
older age, women, higher annual health care costs and
specific conditions. We observed the highest use for
neurological diseases and shoulder operations, while use
was lowest for unspecific medical conditions and non-
orthopedic surgery. Higher deductibles were associated
with lower use. More sessions were associated with a
higher proportion of nine-session episodes and a lower
proportion of new treatments, computed by physician or
physiotherapist. A large range of variation coefficient of
the physiotherapist or the physician was associated with
higher use.
The results of the multivariate analysis are shown in
Table 2. We found a significant link between all of the
above predictors and the number of sessions.
Physical therapy use increased with age until 79 years;
a 70-year-old man had a 4.3% higher use than a 50-year-
old man (as shown by the difference between the two
semi-elasticities, i.e. .260-.217). Use was slightly higher
among women regardless of age (about 2% on average).
Patients with the highest health care spending had al-
most 40% more sessions than people who spent the
least. Shoulder surgery accounted for a 32.4% increase.
Patients with the highest deductible had on average 8.6%
fewer visits than those with the lowest deductibles.
The higher proportion of nine-session episodes was
associated with higher use: switching from the lowest tothe highest proportion increased use by 23% for both
physicians and physiotherapists. A higher proportion of
new treatments had an opposite effect: use shrank by
more than 10% for physiotherapists and by more than
15% for physicians. A larger coefficient of variation, i.e.
better responsiveness, was associated with higher use
(about 8% for both physicians and physiotherapists).
We found no significant link between the number of
sessions and the place of residence (urban or not) and
cantonal indicators (except one). Being treated by several
physicians lowered use, whereas being treated by several
physiotherapists increased use.
Estimates of variance components are shown in
Table 3. Most of the variation in the number of sessions
was due to differences between patients (88.8% of the
total variance) and not between physicians (4.9%) or
physiotherapists (6.3%). The overall variance explained
by the full model was rather weak (11.2%) despite the
large coefficients of most factors.
Our prognostic factors explained a large proportion of
variance between physicians and between physiothera-
pists: 73% and 59%, respectively. For physicians, pricing
rules explained the largest proportion: 25% for the pro-
portion of nine-session sets, and 5% for the proportion
of new treatments. For physiotherapists, it was 17% and
6%, respectively. Health status was an important expla-
natory factor for variations between physicians (8%). Re-
sponsiveness, health factors and context (management
of condition by several physiotherapists) had a similar
predictive ability on variations between physiotherapists
(2 to 3%).
At 4.5%, the proportion of explained variance between
patients was very low. The most powerful prognostic
factor was health status.
Using the back-transformation approach, we found
that switching from the lowest (<600 Swiss francs) to
the next highest deductible (601–1,500 Swiss francs)
would save an average of 0.7 sessions per treatment epi-
sode. Likewise, restricting the proportion of nine-session
episodes to the fourth quintile, i.e. maximum of 73% for
physicians and maximum of 68% for physiotherapists
(upper limit of the 4th quintile) would save a total of 1.4
sessions. Increasing the proportion of new treatments
above the first quintile, i.e. over 60% (upper limit of the
first quintiles for both care providers), would save a total
of 1.1 sessions.
The differences between the least and most parsimoni-
ous practices were 1.3 sessions per treatment for physi-
cians and 2.7 for physiotherapists.
Discussion
The intensity of physical therapy utilization was relatively
high in our population compared to other countries,
which would suggest that effectiveness in Switzerland is
Table 1 Mean volume (number of physical therapy sessions per treatment episode) according to patient,
physiotherapist and referring physician characteristics in the source and studied population
Source population Studied populationa
N (%) or mean value
of the category
Mean volume (SD) N (%) or mean value
of the category
Mean volume (SD)
Variables N = 169,305 12.1 (11.9) N = 87,866 11.7 (10.8)
Patient factors
Age (years)
<18 10,667 (6%) 8.9 (8.3) 6,928 (8%) 8.5 (7.0)
19-39 30,998 (18%) 10.3 (9.5) 18,546 (21%) 9.8 (8.0)
40-59 59,987 (35%) 12.1 (11.4) 31,150 (35%) 11.7 (10.1)
60-79 52,318 (31%) 13.1 (12.6) 24,241 (28%) 13.0 (11.9)
80+ 15,335 (9%) 14.8 (16.4) 7,001 (8%) 14.8 (16.0)
Gender
Male 62,869 (37%) 11.8 (11.9) 35,472 (40%) 11.3 (10.6)
Female 106,436 (63%) 12.3 (12.0) 52,394 (60%) 11.9 (10.9)
Nature of the main condition
Neurological disease 6,086 (4%) 17.5 (22.2) 2,336 (3%) 16.9 (21.4)
Shoulder surgeryb 1,722 (1%) 16.9 (14.4) 337 (0%) 19.0 (15.8)
Muscle diseaseb 1,112 (1%) 14.8 (14.4) 331 (0%) 15.3 (14.7)
Other hip surgeryb 1,827 (1%) 14.6 (13.3) 489 (1%) 13.9 (12.3)
Knee prosthesisb 3,363 (2%) 14.4 (12.7) 661 (1%) 16.9 (13.7)
Rehabilitation 863 (1%) 14.4 (17.0) 285 (0%) 12.5 (11.2)
Hip prosthesisb 4,553 (3%) 13.6 (12.3) 848 (1%) 13.9 (12.2)
Other orthopedicsb 3,055 (2%) 13.6 (13.1) 1,629 (2%) 13.4 (14.4)
Backb 8,563 (5%) 13.5 (13.6) 2,388 (3%) 13.6 (14.3)
Osteoporosisb 5,701 (3%) 13.4 (13.2) 2,474 (3%) 13.6 (12.2)
Cancer 3,178 (2%) 13.1 (13.4) 1,421 (2%) 13.2 (14.2)
Traumab 4,947 (3%) 13.0 (13.6) 2,111 (2%) 12.5 (12.1)
Lymphatic and breast disease 1,587 (1%) 13.0 (12.9) 600 (1%) 12.4 (11.4)
Kneeb 469 (0%) 12.6 (9.2) 173 (0%) 13.4 (10.4)
Rheumatologyb 7,887 (5%) 12.3 (11.7) 3675 (4%) 12.4 (11.3)
Psychiatry 34,242 (20%) 12.3 (11.8) 17,588 (20%) 12.3 (11.5)
Other (medical) 41,592 (25%) 11.0 (9.7) 25,764 (29%) 10.9 (9.0)
Surgery 5,529 (3%) 10.8 (9.0) 3,203 (4%) 10.3 (7.6)
Any of above 33,029 (20%) 10.7 (9.7) 21,553 (25%) 10.4 (8.3)
Comorbidity burden (annual health care costs, mean in 103 CHF)
<1000 27,242 (16%) 10.3 (8.8) 22,319 (25%) 10.1 (8.1)
1001-2000 20,062 (12%) 10.5 (8.3) 13,754 (16%) 10.4 (7.9)
2001-5000 44,321 (26%) 11.2 (8.9) 24,725 (28%) 11.3 (8.6)
5001-10000 36,000 (21%) 12.2 (10.6) 14,805 (17%) 12.5 (10.5)
10001-20000 24,169 (14%) 13.4 (13.0) 7,451 (8%) 14.1 (13.8)
20001-50000 13,626 (8%) 16.1 (18.5) 3,747 (4%) 16.8 (19.2)
>50000 3,885 (2%) 22.3 (30.1) 1,065 (1%) 24.5 (32.8)
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Table 1 Mean volume (number of physical therapy sessions per treatment episode) according to patient,
physiotherapist and referring physician characteristics in the source and studied population (Continued)
Deductibles
<=300 98,499 (58%) 12.4 (12.6) 50764 (58%) 11.9 (11.4)
301-600 55,734 (33%) 12.2 (11.3) 27582 (31%) 11.7 (10.4)
601-1500 11,984 (7%) 10.4 (8.6) 7484 (9%) 10.1 (7.5)
>1500 3,088 (2%) 10.0 (9.5) 2036 (2%) 9.6 (8.3)
Large city residencec
No 104,960 (62%) 12.0 (11.8) 55680 (63%) 11.5 (10.7)
Yes 64,345 (38%) 12.4 (12.0) 32186 (37%) 11.9 (10.9)
Number of physicians per patient
1 98,864 (58%) 11.7 (10.9) 84231 (96%) 11.6 (10.6)
2 45,346 (27%) 12.6 (12.9) 3633 (4%) 12.6 (13.6)
>2 25,095 (15%) 13.1 (13.7) 2 (0%) 5.5 (3.5)
Number of physiotherapists per patient
1 116,868 (69%) 12.1 (11.7) 85332(97%) 11.6 (10.7)
2 39,471 (23%) 12.3 (12.3) 2426 (3%) 12.8 (11.8)
>2 12,966 (8%) 12.0 (12.4) 108 (0%) 13.4 (12.7)
Physician factors
Proportion of treatments by physician as a nine-session episode by quintiles rank
1st 22% 10.5 (11.8) 21% 9.8 (10.1)
2nd 49% 11.1 (11.2) 48% 10.6 (10.3)
3rd 63% 12.4 (12.5) 63% 11.9 (11.3)
4th 73% 13.3 (12.0) 73% 12.8 (11.0)
5th 86% 13.4 (11.9) 85% 13.2 (10.7)
Proportion of new treatments by physician by quintiles rank
1st 48% 15.2 (16.8) 50% 14.3 (15.2)
2nd 60% 12.7 (12.0) 61% 12.0 (10.6)
3rd 65% 11.7 (10.5) 66% 11.5 (9.9)
4th 71% 11.3 (9.8) 72% 10.9 (8.7)
5th 81% 9.8 (7.6) 81% 9.6 (7.1)
Variation coefficient of the physician (by quintiles rank)d
1st 0.45 10.3 (5.8) 0.38 9.9 (4.7)
2nd 0.65 11.4 (7.8) 0.56 10.8 (6.7)
3rd 0.76 11.6 (9.4) 0.67 11.6 (8.3)
4th 0.88 13.0 (12.1) 0.80 11.9 (10.1)
5th 1.19 14.5 (19.3) 1.14 14.1 (18.2)
Physiotherapist factors
Proportion of treatments by physiotherapist as a nine-session episode by quintiles rank
1st 29% 11.0 (12.6) 30% 10.2 (11.2)
2nd 46% 11.2 (11.1) 47% 10.8 (10.4)
3rd 56% 12.0 (11.4) 56% 11.4 (10.0)
4th 68% 12.8 (12.3) 68% 12.4 (10.7)
5th 84% 13.8 (11.9) 84% 13.5 (11.1)
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Table 1 Mean volume (number of physical therapy sessions per treatment episode) according to patient,
physiotherapist and referring physician characteristics in the source and studied population (Continued)
Proportion of new treatments by physiotherapist by quintiles rank
1st 49% 14.9 (16.9) 51% 14.2 (15.0)
2nd 60% 12.6 (11.7) 61% 12.0 (10.5)
3rd 66% 11.8 (10.8) 51% 14.2 (10.0)
4th 71% 11.0 (9.4) 61% 12.0 (8.6)
5th 80% 10.3 (8.4) 67% 11.5 (7.7)
Variation coefficient of the physiotherapist (by quintiles rank)e
1st 0.53 10.8 (6.4) 0.46 10.4 (5.6)
2nd 0.68 11.4 (8.2) 0.61 10.7 (7.0)
3rd 0.78 11.7 (9.6) 0.70 11.4 (8.4)
4th 0.89 12.5 (11.8) 0.81 11.7 (9.9)
5th 1.20 14.3 (19.1) 1.13 14.1 (18.0)
aRestricted to the first treatment episode per patient and patients treated by a physiotherapist and a physician with at least two observations (allowing a value of
the coefficient of variation).
bReferred to as musculoskeletal conditions in the manuscript.
cIn one of the 62 largest cities.
dN = 167,196 because of missing values of the coefficient of variation.
eN = 168,979 because of missing values of the coefficient of variation.
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adults, the average number of visits per episode was 9.6
[13], whereas an older population of Medicare beneficia-
ries attended a mean of 6.8 appointments for musculo-
skeletal conditions [38]. In the Netherlands, the treatment
of similar conditions required an average of 10.5 visits
[39]. A cross-country comparison found substantial vari-
ation in the type of treatment given and the number of
visits per episode [2]. In this study, corrected for age, gen-
der and episode duration, mean numbers were 10.0 in the
US, 6.5 in Israel and 10.0 in the Netherlands.
Our study confirms that the considerable variation in
the intensity of physical therapy per treatment episode
depends on both health-related and non-health related
factors.
Poorer health status, reflected by higher health care
costs, was associated with a higher number of visits. A
higher number of sessions among women was consistent
with their usual higher level of care use [40]. The gender
difference might also be related to non-measured mor-
bidity, such as levels of pain or impairment, which tend
to be more severe for women with musculoskeletal com-
plaints than for their male counterparts [41]. Like other
studies, we found that shoulder and knee impairments
were associated with more visits [38] and that having
surgery also increased the number of visits [42]. The de-
cline in use among the oldest age groups has also been
found by other studies [43,44].
Insurance status was consistently shown to affect the
use of physical therapy services [43,44]; higher deductiblesdecreased utilization, suggesting underuse among patients
who chose the highest out-of-pocket payment option.
More physical therapy sessions were associated with
physicians and physiotherapists with the best responsive-
ness (i.e. highest coefficients of variation).
The higher proportion of nine-session sets was associ-
ated with more intense use of physical therapy, indica-
ting that prescription caps did not hinder the number of
sessions per episode. Restricting the number of sessions
has been the standard payment policy to limit overuse.
Our findings, however, challenge its effectiveness. In
Israel, where there is no cap but rather long waiting lists,
patients with acute complaints receive more sessions
than those with chronic complaints, probably because
the expected improvement is better among the former
group [2]. In Switzerland, the ceiling is set at nine ses-
sions, corresponding to the median number of sessions.
This cap might have no moderating effect on the many
patients requiring less than nine sessions and may, in
fact, encourage the provision of 18 sessions to patients
who would require slightly more than nine sessions. We
recommend a lower ceiling for the majority of acute
conditions, as the literature and our own data would
suggest that six sessions per prescription in non-surgery
conditions is adequate [2,17,45].
Physiotherapists with a higher rate of new treatments
tended to provide fewer sessions than others. This might
indicate that physiotherapists tend to compensate for
the smaller volume of new patients by extending the
treatment of existing patients. However, we found the
Table 2 Multilevel regression analysis of the number of
physiotherapy sessiona
Model coefficientsc
Factorsb Estimates
(i.e. semi-elasticities)
95% confidence
interval
Patient needs
Age and gender
[20-39] men .088 .062- .114
[40–59] men .217 .193- .242
[60–79] men .260 .235- .285
[80 + ] men .211 .175- .247
[20-39] women .095 .071- .120
[40–59] women .232 .208- .255
[60–79] women .291 .266- .315
[80 + ] women .259 .230- .288
Conditionsd
Shoulder operation .324 .257- .391
Total knee prosthesis .252 .203- .301
Muscular disease .175 .107- .242
Neurological diseases .081 .053- .109
Other orthopedic surgery .043 .011- .074
Osteoporosis .035 .008- .062
Rheumatic conditions .024 .002- .047
Other surgery -.043 -.067- -.019
Lymphatic problems -.055 -.106- -.004
Rehabilitation -.084 -.157- -.011
Comorbidity burden
(annual costs 103 CHF)
1,001–2,000 .020 .006- .033
2,001–5,000 .065 .053- .077
5,001–10,000 .130 .115- .144
10,001–20,000 .180 .162- .198
20,001–50,000 .223 .199- .246
>50,000 .381 .340- .421
Provider practices
Variation coefficient of the
physician (by quintiles rank)
2nd .043 .028- .058
3rd .062 .046- .078
4th .062 .046- .078
5th .082 .065- .099
Table 2 Multilevel regression analysis of the number of
physiotherapy sessiona (Continued)
Variation coefficient of the
physiotherapist
(by quintiles rank)
2nd .019 .000- .038
3rd .037 .018- .057
4th .065 .044- .086
5th .087 .067- .107
Funding regulations
Deductibles (CHF)
601–1,500 -.060 -.076- -.044
>1,500 -.086 -.115- -.058
Ceiling per prescription
(proportion of treatments
by physician as a
nine-session episode
by quintiles rank)
2nd .080 .064-.097
3rd .154 .137- .171
4th .205 .188- .223
5th .235 .216- .254
Ceiling per prescription
(proportion of treatment
by physiotherapist as a
nine-session episode by
quintiles rank
2nd .081 .059- .103
3rd .114 .092- .136
4th .155 .132- .177
5th .227 .202- .252
Proportion of new
treatments by physician
by quintiles rank
2nd -.050 -.066- -.033
3rd -.058 -.074- -.041
4th -.095 -.112- -.078
5th -.154 -.171- -.137
Proportion of new
treatments by
physiotherapist by
quintiles rank
2nd −0.045 -.064- -.025
3rd −0.071 -.091- -.051
4th −0.081 -.101- -.060
5th −0.104 -.125- -.082
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Table 2 Multilevel regression analysis of the number of
physiotherapy sessiona (Continued)
Context variablese
Being treated by more
than one physician
-.083 -.122- -.045
Being treated by more
than one physiotherapist
.060 .015- .105
Residency canton
(13 dummy variables)
Only one had a significant
coefficient
.042 .006-.078
Model constant 1.732 1.688-1.776
aAnalysis was restricted to the patients’ first treatment.
bOnly variables with a coefficient significantly different from 0 (p < 0.05) are shown.
cThe model coefficients can be interpreted as semi-elasticities, i.e. the percentage
change of the outcome after a unit change of the explanatory variable. The
reference category was: men, < 20 y, no condition identified from drugs
prescriptions, inpatient diagnoses or a specialist contact, deductibles < CHF 600,
being treated by one physician and one physiotherapist in the lowest quintiles
rank for all their variables, and not resident in a large city.
dThe following conditions had no significant effect: cancer, mental conditions,
back problems, other knee problems, total hip prosthesis, other hip surgery,
other trauma, and other medical condition.
eUrban residence had no significant effect.
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apy referrals was associated with lower intensity of phys-
ical therapy use), even though they have no financial
incentives. This finding may also reflect differences in
the population served: patients with chronic complaints
generally received more sessions than those with acute
ailments, provided there is not an undersupply of phy-
siotherapists [17].
Contrary to several studies elsewhere, we did not find
significant variations across urban and rural residency
and across geographical areas, which would indicate that
there was no overt rationing of physical therapy inTable 3 Proportion of variation explained by grouping struct
Variance explained in % (PEV)a
Funding regulation
Varianceb ICCc Context Health
factors
Deductibles % N
trea
By grouping levele
Physician .021 .049 .000 .079 .000 .048
Physio. .028 .063 .022 .033 .000 .055
Patient .393 .888 .000 .040 .001 .002
Overall .442 1
aThe proportion of explained variation (PEV, i.e. squared semi-partial correlation coe
included in the model.
bTotal variance potentially explained at all levels.
cThe intra-class correlation coefficient (ICC) allows the partitioning of the total variabilit
and patients.
dUnless the regressors are all orthogonal, the prognostic factors’ specific PEVs do no
due to the inclusion of all regressors into the model.
eThe third level (canton) was treated as a fixed effect and therefore no variance comSwitzerland. However, more homogenous health services
area than cantons on factors that determine provision
and utilization of health resources might yield different
findings.
The proportion of explained variation (PEV) by phy-
sician and physiotherapist characteristics represented only
a small component of total variance (5% and 6% res-
pectively). The factors introduced in the model largely
explained more than half of the associated PEV (levels 2
and 2’), thereby illustrating that unobserved provider-
related variables would not improve the model signifi-
cantly. Funding rules in Switzerland, especially caps, were
the most important determinants. Health factors accoun-
ted for a larger proportion of variation among physicians
(7.9%) than among physiotherapists (3.3%). This is not
surprising given that the two health care providers base
their decisions on different models: physicians use the bio-
medical model which is based on diagnosis, while physio-
therapists apply the biopsychosocial model which is based
on functional deficit [46].
These findings suggest that providers tend to maxi-
mize the benefits offered by the regulations (not neces-
sarily for their own benefit but rather for ensuring
patient satisfaction). Not only does this highlight the
need to review the current nine-session ceiling but it
also argues in favor of further studies that explore finan-
cial incentives with the achievement of better clinical
outcomes [45].
Episodes with multiple medical referrals were asso-
ciated with fewer sessions, probably reflecting a frac-
tioning of episodes. The inverse relation observed for
physiotherapists might reflect complex and chronic con-
ditions requiring the involvement of several physiothera-
pists, or the fact that a colleague replaces the attendant
physiotherapist in their absence, which is a commonure and covariates
s
ew
tments
% Nine
sessions series
Responsiveness Collinearityd Total
.251 .029 .323 .730
.174 .032 .274 .590
.000 .000 .002 .045
.112
fficient) represents the amount of variance that is explained by the regressors
y in the outcome into its three variance components: physicians, physiotherapists
t add up to the total PEV, the difference representing the collinearity effect
ponent appears in the disaggregation of the total variance.
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cient account of the duration of complaints, which has
been consistently associated with higher use [2,12,17].
Of the total unconditional variance, the largest share
was attributable at the patient level (89%). However, pa-
tient characteristics, such as health conditions, explained
only 4% of this variance (Table 3), suggesting that the
main determinants of variability were unmeasured.
This unexplained large variation in utilization has been
found in other studies, even in those which encompass
more detailed clinical information or consider only spe-
cific conditions [38]. This degree of variation, which does
not appear to be attributable to illness severity or disease
characteristics, is generally viewed as a potential threat to
overall quality of care. However, there must be many un-
measured factors over which the provider has little control
like psychosocial variables, including pain behavior, nega-
tive beliefs or coping style. Functional status is certainly
also of interest but not routinely recorded. Inappropriate
factors like patient requests that yield no benefits might
also be part of the unexplained variation. Studies have
shown that physicians’ clinical decision-making is heavily
influenced by patients’ persistent requests for various ser-
vices, which themselves depend more on subjective health
complaints than on objective morbidity burden as mea-
sured by a count of chronic conditions [47]. Providers
might also be reluctant to restrict the provision of physical
therapy services when they do not have a satisfactory
alternative to offer their patients. Finally, medical inter-
vention can have psychologically mediated benefits, even
when medically unnecessary. As a result, it would be
probably insufficient to undertake basic efficiency moni-
toring according to the expected number of required ses-
sions. Monitoring of chronic high users should be based
on a review of the treatment plan according to the follo-
wing criteria: expected number of sessions to reach de-
fined goals, compliance with the treatment plan and
improvement of functional outcomes [45].
Data on the relationship between the intensity of
physical therapy use and outcomes are scarce and con-
tradictory. According to several studies, attending more
sessions was associated with an improvement in most
functional outcomes [38]. However, poorer outcomes as-
sociated with more visits among patients suffering from
back problems suggested a tendency among therapists to
add appointments when outcomes did not improve [48].
For neck pain, standard physical therapy may be only
marginally better than a brief physical therapy interven-
tion which encourages self-management [49].
Limitations
The main limitation of the study is its reliance on rou-
tinely available data. Several important utilization drivers
at the patient level were missing, such as functionaldisability, behavioral factors and symptom severity. Con-
sidering that variance in the number of sessions is found
predominantly at the patient level, additional research
should focus on the contribution of these factors (pos-
sibly also using qualitative research methods) to devise
strategies to improve the adequacy of physiotherapy use.
Given that psychosocial factors, such as catastrophizing,
fear avoidance, and poor coping skills, are known to be
important predictors of outcome among musculoskeletal
conditions, interventions that deal with patients’ beliefs
and attitudes might therefore help to hasten recovery
[49]. This is in line with the increasing support among
physiotherapists of the biopsychosocial model of care
[50]. Finally, as no information was available on patient
satisfaction or outcomes, we cannot conclude from
the study that opportunities exist to reduce physical
therapy use.
A second limitation concerns the studied population.
Theoretically, there are three possible sources of bias: 1)
during the selection of the studied population (exclusion
of patients who left their insurance company in 2006); 2)
in selecting first episodes (multiple episodes); 3) exclu-
sion of episodes with a final session during the second
semester of 2006. We believe that there are several rea-
sons why such bias had no significant impact on our re-
sults. First, only 17% of insured left their insurance
company in 2006. Secondly, the large size of the sample
and the comparisons between the source and studied
population support the representativeness of the data in
terms of physical therapy practices for the whole coun-
try. Thirdly, less than 3% of episodes began in 2005 and
ended during the second semester of 2006. The exclu-
sion of certain protracted episodes should not alter the
analysis of the general behavior of patients, physicians
and physiotherapists.
Although the data we used were eight-years-old, there
have been no cost management changes in the inter-
vening period, and the utilization patterns found in
the study can be reliably generalized to the current
situation.Conclusion
Against the backdrop of abundant physical therapy supply,
financial incentives as applied in Switzerland (nine-session
ceiling, higher reimbursement for new treatments) did not
restrict utilization. The multilevel regression analysis ex-
hibited no cantonal variations, but found small variations
between physicians and physiotherapists, and revealed
that most of the variance was at the patient level. This
suggests that regulation should focus more on patients
and that further research is required to understand the
determinants of patient demand and the effectiveness of
physical therapy.
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